You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DMRA Award Disclosure
Cheng Andrew · SEC Form 4 · Filed Aug 13, 2026
Award
Calculated transaction value
$0
Cheng Andrew Director
DMRA
Transaction date
Aug 12, 2026
Public filing date
Aug 13, 2026
Filing lag
Filed 1 day later
DMRA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Ordinary Shares
- Quantity / price
- 30,350 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-349537
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Damora Therapeutics, Inc. DMRA Current | Award | Aug 12, 2026 | $0 |